[The dilemma of the Brazilian cardiologist: should the thrombolytic agent be changed?].
Piegas
L S
LS
Instituto Dante Pazzanese de Cardiologia - São Paulo.
Sousa
A G
AG
Sousa
J E
JE
D001938:Brazil; D003365:Costs and Cost Analysis; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D015912:Thrombolytic Therapy
D005343:Fibrinolytic Agents
O dilema do cardiologista brasilerio. Mudar de trombolítico?